Modelling the expected increase in demand for particle radiotherapy: Implications for the UK

British Journal of Radiology

Volumn 78, Issue 933, 2005, Pages 832-835

  Jones, B ^a   Price, P ^b   Burnet, N G ^c   Roberts, J T ^d  

^a QUEEN ELIZABETH HOSPITAL   (United Kingdom)

^b CHRISTIE HOSPITAL   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d NEWCASTLE GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER SCREENING; CLINICAL PRACTICE; CONTROLLED STUDY; HEALTH CARE DELIVERY; HEALTH CARE FACILITY; HEALTH CARE NEED; HEALTH CARE QUALITY; HUMAN; MALIGNANT NEOPLASTIC DISEASE; MODEL; MORBIDITY; PATIENT REFERRAL; RADIATION INJURY; RADIOTHERAPY; TREATMENT OUTCOME; UNITED KINGDOM;

GREAT BRITAIN; HUMANS; MODELS, THEORETICAL; PARTICLE ACCELERATORS; RADIOTHERAPY;

EID: 24344478658     PISSN: 00071285     EISSN: None     Source Type: Journal    
DOI: 10.1259/bjr/39644382     Document Type: Article

References (16)

1. Ringborg U, Bergqvist D, Brorsson B, Cavallin-Stahl E, Ceberg J, Einhorn N, et al. The Swedish Council on Technology Assessment in health care (SBU) systematic overview of radiotherapy for cancer including a prospective survey of radiotherapy practice in Sweden 2001 - summary and conclusions. Acta Oncol 2003;42:357-65.
2. NcNee SG, Rampling R, Dale AJ, Gregor A. An audit of 3D treatment planning facilities and practice in the UK. Clin Oncol 1998;10:18-23.
3. Burnet NG. Editorial: 3-Dimensional treatment planning for radiotherapy. Clin Oncol 1998;10:1-21.
4. Suit H, Goldberg S, Niemerko A, Trofinov A, Adams J, et al. Proton beams to replace photon beams in radical dose treatments. Acta Oncologica 2004;22:2246-50.
5. Turreson I, Johansson KA, Mattsson S. The potential of proton and light ion beams in radiotherapy. Acta Oncol 2003;42:107-14.
6. Pommier P, Balosso J, Bolla M, Gerard JP. The French project ETOILE: review of clinical data for light ion hadrontherapy. Cancer Radiother 2002;6:369-78.
7. Brahme A. Recent advances in light ion radiation therapy. Int J Radiat Oncol Biol Phys 2004;58:603-16.
8. Amaldi U. Future trends in cancer therapy with particle accelerators. Z Med Phys 2004;14:7-16.
9. Svensson H, Moller TR. SBU Survey Group. Developments in radiotherapy. Acta Oncol 2003;42:430-42.
10. Jones B, Rosenberg I. Particle Therapy Cooperative Oncology Group (PTCOG40) Meeting, Institute Curie 2004. Br J Radiol 2005;78:99-102.
11. Jones B, Price P. Editorial: Proton therapy: expanding clinical indications. Clin Oncol 2004;16:324-5.
12. Price P, Errington RD, Jones B. Report on the UK meeting September 2001 to discuss the clinical and scientific case for a high energy proton therapy facility in the UK. Clin Oncol 2003;15:S1-9.
13. Goitein M, Jermann M. The relative costs of proton and X-ray radiation therapy. Clin Oncol 1993;15:S37-50.
14. Miralbell R, Lomax A, Cella L, Schneider U. Potential reduction of the incidence of radiation-induced second cancers by using proton beams in the treatment of pediatric tumors. Int J Radiat Oncol Biol Phys 2002;54:824-9.
15. Jones B, Dale RG. Radiobiologically based assessment of the net costs of fractionated focal radiotherapy. Int J Radiat Oncol Biol Phys 1998;41:1139-48.
16. Bentzen SM. High tech in radiation oncology: should there be a ceiling? Int J Radiat Oncol Biol Phys 2004;58:320-30.